Breast cancer in young women – understanding the risks and challenges
By Dr Vanitha Budhavaram, Specialist Breast Surgeon, Joondalup, Midland and Subiaco Breast cancer is often thought of as...
chemotherapy
From radical to restorative – a history of surgical treatment of breast cancer
Breast cancer remains a challenging diagnosis, transforming many aspects of patients’ lives beyond physical health. By Dr David...
Chemo causes cancer?
Counterintuitively, a US study has found that a standard chemotherapy drug used to treat breast cancer could reawaken dormant cancer cells, causing them to grow. Read More...
Common Medicine may work against lung cancer treatment
A medicine commonly prescribed to treat reflux, heart burn and ulcers may reduce the effectiveness of lung cancer immunotherapy drugs. Read More...
Perth Research: new treatment brings hope for rare cancer
A new treatment combining standard chemotherapy with an immunotherapy agent may provide a long overdue improvement in the treatment of mesothelioma. Read More...
Subclinical heart failure post cancer chemotherapy
Unfortunately, some therapies required to cure or control the cancer are cardiotoxic. This can lead to subclinical and clinical heart failure (HF) in patients with or without underlying cardiac risk factors. Cancer therapeutics related cardiac dysfunction (CTRCD) might lead to interruption or alteration of cancer therapy. Some patients can present weeks and years after treatment. Read More...